ROLE OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN ELDERLY HYPERTENSIVES WITH COMORBIDITY: FROM CLINICAL TRIALS TO REAL WORLD

被引：0
|
作者：
Mazza, Alberto [1 ]
Torin, Gioia [2 ]
Schiavon, Laura [2 ]
Rossetti, Ciro [2 ]
Cuppini, Stefano [2 ]
机构：
[1] Rovigo Gen Hosp, AULSS5 Polesana, ESH Excellence Hypertens Ctr, Rovigo, Italy
[2] Rovigo Gen Hosp, AULSS5 Polesana, Internal Med Unit, Rovigo, Italy
来源：
JOURNAL OF HYPERTENSION | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E279 / E279
页数：1
相关论文
共 50 条
  • [21] Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study)
    Di Lenarda, Andrea
    Di Gesaro, Gabriele
    Sarullo, Filippo Maria
    Miani, Daniela
    Driussi, Mauro
    Correale, Michele
    Bilato, Claudio
    Passantino, Andrea
    Carluccio, Erberto
    Villani, Alessandra
    degli Esposti, Luca
    d'Agostino, Chiara
    Peruzzi, Elena
    Poli, Simone
    Iacoviello, Massimo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [22] Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
    Raschi, Emanuel
    Diemberger, Igor
    Sabatino, Mario
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Potena, Luciano
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 303 - 320
  • [23] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [24] Sacubitril/valsartan in chronic heart failure with reduced ejection fraction: a guide to its use
    Keating G.M.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2017, 33 (1) : 1 - 7
  • [25] The cost-effectiveness of sacubitril/valsartan in chronic heart failure with reduced ejection fraction
    Mcmurray, J. J. V.
    Cowie, M. R.
    Briggs, A.
    Taylor, M.
    Hancock, E.
    Trueman, D. David
    Haroun, R.
    Deschaseaux, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 276 - 276
  • [26] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [27] THE COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN TURKEY
    Sarioz, F.
    Ozdemir, O.
    Direk, S.
    Caglar, P.
    Ar, I
    VALUE IN HEALTH, 2017, 20 (09) : A616 - A616
  • [28] PHARMACOUTILIZATION AND ADHERENCE TO SACUBITRIL/VALSARTAN IN REAL-WORLD: THE REAL.IT STUDY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Iacoviello, M.
    Di Gesaro, G.
    Sarullo, F.
    Miani, D.
    Driussi, M.
    Correale, M.
    Bilato, C.
    Passantino, A.
    Carluccio, E.
    Villani, A.
    Esposti, L. Degli
    D'Agostino, C.
    Peruzzi, E.
    Poli, S.
    Di Lenarda, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [29] Economic evaluation of sacubitril/valsartan for the treatment of chronic heart failure with reduced ejection fraction (HFrEF) in Indonesia
    Kristin, Erna
    Dwi-Endarti
    Febrinasari, Ratih Puspita
    Nugrahaningsih, Dwi Aris Agung
    Pratiwi, Woro Rukmi
    Indrajaya, Sudi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 129 - 130
  • [30] Sacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study
    Yang, Ying
    Shen, Chao
    Lu, Jiangting
    Fu, Guosheng
    Xiong, Cui
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 177 - 182
12345